UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study

European journal of cancer (1990), 2021-04, Vol.147, p.29-39

2021

Volltextzugriff (PDF)

EE324 Cost-Effectiveness analysis of Atezolizumab as Adjuvant Treatment of Patients With Stage II-IIIA Non-Small Cell Lung Cancer, With Pd-L1≥50% of Tumor Cells, in France

Value in health, 2022-12, Vol.25 (12), p.S117-S118

2022

Volltextzugriff (PDF)

Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5910-5917

2005

Volltextzugriff (PDF)

Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel

Molecular cancer therapeutics, 2005-12, Vol.4 (12), p.2001-2007

2005

Volltextzugriff (PDF)

Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

Clinical cancer research, 2005-08, Vol.11 (15), p.5481-5486

2005

Volltextzugriff (PDF)

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer : Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

Annals of oncology, 2001, Vol.12 (1), p.59-67

2001

Volltextzugriff (PDF)

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Annals of oncology, 2005-04, Vol.16 (4), p.602-610

2005

Volltextzugriff (PDF)

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection

The Annals of thoracic surgery, 2005-08, Vol.80 (2), p.423-427

2005

Volltextzugriff (PDF)

Primary sarcomas of the lung: A clinicopathologic study of 12 cases

Lung cancer (Amsterdam, Netherlands), 2002-12, Vol.38 (3), p.283-289

2002

Volltextzugriff (PDF)

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2005-09, Vol.49 (3), p.363-370

2005

Volltextzugriff (PDF)

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients

Annals of oncology, 2002-12, Vol.13 (12), p.1853-1861

2002

Volltextzugriff (PDF)

Pulmonary Function in Patients Receiving Long-term Low-dose Methotrexate

Chest, 1996-04, Vol.109 (4), p.933-938

1996

Volltextzugriff (PDF)

Lessons from the 'Iressa' Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

British journal of cancer, 2003-12, Vol.89 (S2), p.S19-S23

2003

Volltextzugriff (PDF)

Carboplatin—etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial

Lung cancer (Amsterdam, Netherlands), 2002, Vol.35 (1), p.1-7

2002

Volltextzugriff (PDF)

Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense

Revue des maladies respiratoires, 2012-03, Vol.29 (3), p.435-439

2012

Volltextzugriff (PDF)

The role of chemotherapy in early stage of non-small cell lung cancer

Lung cancer, 2001-12, Vol.34, p.S155-S158

2001

Volltextzugriff (PDF)

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

British journal of clinical pharmacology, 2000-10, Vol.50 (4), p.315-324

2000

Volltextzugriff (PDF)

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

British journal of cancer, 2003-08, Vol.89 (S1), p.S35-S49

2003

Volltextzugriff (PDF)

Rhabdomyosarcoma arising in mediastinal teratoma in an adult man: a case report

Annals of oncology, 2002-02, Vol.13 (2), p.323-326

2002

Volltextzugriff (PDF)

A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer

European journal of cancer (1990), 1996, Vol.32 (1), p.69-71

1996

Volltextzugriff (PDF)

Critères incitant à initier un traitement d’infection pulmonaire chronique à mycobactérie non tuberculeuse chez des individus immunocompétents sans pathologie pulmonaire chronique

Médecine et maladies infectieuses, 2017-06, Vol.47 (4), p.S105-S105

2017

Volltextzugriff (PDF)

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)

Lung cancer (Amsterdam, Netherlands), 2001-02, Vol.31 (2-3), p.247-256

2001

Volltextzugriff (PDF)

Hodgkin's disease associated with IgA and IgG subclass deficiency

Journal of internal medicine, 1996-08, Vol.240 (2), p.99-102

1996

Volltextzugriff (PDF)

Treatment of bronchial carcinoma in the elderly

Revue des maladies respiratoires, 2002-10, Vol.19 (5 Pt 1), p.616

2002

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(48)

Sprache

Englisch
(32)
Französisch
(16)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(32)
Oncology
(23)
Male
(21)
Aged
(19)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Female
(18)
Adult
(17)
Middle Aged
(17)
Lung Neoplasms - Drug Therapy
(12)
Lung Neoplasms - Pathology
(11)
Respiratory System
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Cisplatin - Administration & Dosage
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Combined Modality Therapy
(8)
Survival Analysis
(8)
Chemotherapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study

EE324 Cost-Effectiveness analysis of Atezolizumab as Adjuvant Treatment of Patients With Stage II-IIIA Non-Small Cell Lung Cancer, With Pd-L1≥50% of Tumor Cells, in France

Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study

Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel

Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer : Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection

Primary sarcomas of the lung: A clinicopathologic study of 12 cases

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients

Pulmonary Function in Patients Receiving Long-term Low-dose Methotrexate

Lessons from the 'Iressa' Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

Carboplatin—etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial

Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense

The role of chemotherapy in early stage of non-small cell lung cancer

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

Rhabdomyosarcoma arising in mediastinal teratoma in an adult man: a case report

A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer

Critères incitant à initier un traitement d’infection pulmonaire chronique à mycobactérie non tuberculeuse chez des individus immunocompétents sans pathologie pulmonaire chronique

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)

Hodgkin's disease associated with IgA and IgG subclass deficiency

Treatment of bronchial carcinoma in the elderly

Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients

Suchergebnisse filtern